FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland, January 30, 2014. REUTERS/Ruben Sprich/File Photo (Reuters) – Swiss drugmaker Roche (ROG.S) will buy U.S. cancer drugmaker Ignyta Inc (RXDX.O) ... More »
(Reuters) – Ignyta Inc is in advanced talks to sell itself, people familiar with the matter said on Thursday, just three years after the U.S. cancer drugmaker became a public company focused on precision drugs and diagnostics. The deal would come as large phar... More »
We use cookies!
By using this site you agree to the use of cookies, more info.